India's second biggest lab group by revenue is planning further acquisitions in 2018 on the back of volume-led growth and rising profits, the company announced today as it posted its Q3 results.
GCC and Indian healthcare group Aster DM is finally set to IPO on February 12-16 and is seeking to raise US$150m for a valuation of US$1.5bn - figures 50% and 40% lower than when it filed two years ago.
LIH Skycity rehabilitation hospital in Kunming opened last year, with the aim of bringing American paediatric expertise to southwest China. CEO Dr Christian Orejudos tells Healthcare Nova the project has been challenging.
Private equity group Abraaj has been cleared of misappropriating funds from its US$1bn Abraaj Growth Markets Health Fund by the outside accountants hired by its investors following reports money had been mishandled. The saga highlights the difficulties and delays in deploying capital in emerging markets.
The man who helped turn Al Noor into a US$1bn company is building what he claims is the first major value healthcare platform in the UAE focused on serving the working class. Healthcare Nova chats to Abhishek Sharma, CEO of Foundation Holdings which has just launched Right Health with a view to IPO by 2021.
Unilever runs a global health and prevention programme in over 90 countries for its 169,000 employees. How? What does Dr Thirumalai (known as Dr Raj) think of the private healthcare services sector? And what changes does he expect in the future? And what does he expect from digital health and AI? Dr Raj is also a non-executive independent director of Apollo Hospitals Enterprise and a speaker at HBI 2018 on April 10-11 in London.
The China Securities Regulatory Commission has rejected the country’s largest private psychiatric hospital group Wenzhou Kangning’s application to list on Shanghai stock exchange.
There are two striking things about our interview with Group CEO Charles Wang at Luye Medical. First is how long-term its strategy is and secondly, and most intriguingly, is how it plans to import models into China. Luye went out and purchased the third largest Australian hospital group and the second largest oncology player in […]
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
